Hyaluronan-based hydrogels as dermal fillers: The biophysical properties that translate into a "volumetric" effect.


Journal

PloS one
ISSN: 1932-6203
Titre abrégé: PLoS One
Pays: United States
ID NLM: 101285081

Informations de publication

Date de publication:
2019
Historique:
received: 19 03 2019
accepted: 29 05 2019
entrez: 12 6 2019
pubmed: 12 6 2019
medline: 11 2 2020
Statut: epublish

Résumé

Biophysical and biochemical data on hyaluronan (HA)-based dermal fillers strongly support their optimal use and design to meet specific requisites. Here, four commercially available (in Europe) HA "volumetric" fillers, among the most used in the clinical practice, have been characterized in vitro. Analyses revealed the highest amounts of water-soluble HA reported so far and provided hydrodynamic data for these soluble polymeric fractions. Volumetric gels exhibit a wide range of rigidity with most of them showing G' values around 200-300Pa. They greatly differ in cohesivity. 1mL of gel hydrates up to 2.4-3.2mL. The products completely solubilize due to Bovine Testicular Hyaluronidase (BTH)'s action, thus predicting in vivo complete resorption. For the first time, filler degradation due to reactive oxygen species (ROS) was studied by rheological measurements and a rank in stability was established. Studies using Human Dermal Fibroblasts (HDF) indicated a positive biological response to the HA networks. Further, gel capacity to prompt collagen I, elastin and aquaporin3 synthesis was demonstrated, thus suggesting a positive effect on skin elasticity and hydration, besides the physical volumetric action. The findings are the first wide assessment of features for the volumetric class of HA-fillers and include first data on their resistance to degradation by ROS and biological effects on HDF. The study represents a valuable contribution to the understanding of HA-fillers, useful to optimize their use and manufacture.

Identifiants

pubmed: 31185059
doi: 10.1371/journal.pone.0218287
pii: PONE-D-19-07885
pmc: PMC6559669
doi:

Substances chimiques

Collagen Type I 0
Dermal Fillers 0
Hydrogels 0
Hyaluronic Acid 9004-61-9

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

e0218287

Déclaration de conflit d'intérêts

The authors have declared that no competing interests exist.

Références

Dermatol Surg. 2007 Dec;33 Suppl 2:S136-43; discussion S143
pubmed: 18086051
Mater Sci Eng C Mater Biol Appl. 2016 Nov 1;68:565-572
pubmed: 27524055
Facial Plast Surg. 2009 May;25(2):86-94
pubmed: 19415575
Plast Reconstr Surg. 2014 Dec;134(6):1224-33
pubmed: 25415091
Plast Reconstr Surg. 2018 Jul;142(1):112-121
pubmed: 29952893
Int J Cosmet Sci. 2017 Aug;39(4):355-360
pubmed: 28027572
J Dermatol Sci. 2013 Mar;69(3):187-94
pubmed: 23340440
Int J Biol Macromol. 2018 Dec;120(Pt B):1682-1695
pubmed: 30287361
Anal Biochem. 1962 Oct;4:330-4
pubmed: 13971270
Arch Dermatol. 2007 Feb;143(2):155-63
pubmed: 17309996
Carbohydr Polym. 2016 Nov 20;153:275-283
pubmed: 27561497
Facial Plast Surg Clin North Am. 2015 Nov;23(4):423-32
pubmed: 26505539
Clin Interv Aging. 2008;3(4):629-34
pubmed: 19281055
J Invest Dermatol. 2013 Mar;133(3):658-667
pubmed: 23096713
Facial Plast Surg Clin North Am. 2015 Nov;23(4):417-21
pubmed: 26505538
Plast Reconstr Surg. 2015 Nov;136(5 Suppl):188S-195S
pubmed: 26441098
Acta Biomater. 2013 Jul;9(7):7081-92
pubmed: 23507088
PLoS One. 2016 Oct 10;11(10):e0163510
pubmed: 27723763
Plast Reconstr Surg. 2013 Oct;132(4 Suppl 2):5S-21S
pubmed: 24077013
Clin Plast Surg. 2016 Jul;43(3):489-96
pubmed: 27363762
Toxicol Lett. 2016 May 13;249:1-4
pubmed: 27016407
J Cosmet Laser Ther. 2008 Mar;10(1):35-42
pubmed: 18330796
J Immunol Methods. 1983 Dec 16;65(1-2):55-63
pubmed: 6606682
Dermatol Surg. 2012 Jul;38(7 Pt 2):1170-9
pubmed: 22759254
Carbohydr Polym. 2013 Jul 25;96(2):536-44
pubmed: 23768598
Methods Find Exp Clin Pharmacol. 2001 Mar;23(2):65-71
pubmed: 11484412
J Drugs Dermatol. 2010 May;9(5):458-65
pubmed: 20480788
Facial Plast Surg. 2017 Feb;33(1):87-96
pubmed: 28226376
J Biomed Mater Res A. 2008 Oct;87(1):264-71
pubmed: 18200557
Dermatol Surg. 2009 Feb;35 Suppl 1:302-12
pubmed: 19207319
Anal Biochem. 2010 Sep 1;404(1):21-9
pubmed: 20399193
Plast Reconstr Surg. 2015 Oct;136(4):678-86
pubmed: 26397245
Dermatol Surg. 2018 Apr;44(4):557-562
pubmed: 29059137
Ann Dermatol. 2014 Jun;26(3):357-62
pubmed: 24966636

Auteurs

Annalisa La Gatta (A)

Department of Experimental Medicine, School of Medicine, University of Campania "Luigi Vanvitelli", Naples, Italy.

Rosanna Salzillo (R)

Department of Experimental Medicine, School of Medicine, University of Campania "Luigi Vanvitelli", Naples, Italy.

Claudia Catalano (C)

Department of Experimental Medicine, School of Medicine, University of Campania "Luigi Vanvitelli", Naples, Italy.

Antonella D'Agostino (A)

Department of Experimental Medicine, School of Medicine, University of Campania "Luigi Vanvitelli", Naples, Italy.

Anna Virginia Adriana Pirozzi (AVA)

Department of Experimental Medicine, School of Medicine, University of Campania "Luigi Vanvitelli", Naples, Italy.

Mario De Rosa (M)

Centro Regionale di Competenza in Biotecnologie Industriali BioTekNet S.C.p.A. c/o University of Campania "Luigi Vanvitelli", Naples, Italy.

Chiara Schiraldi (C)

Department of Experimental Medicine, School of Medicine, University of Campania "Luigi Vanvitelli", Naples, Italy.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH